The Global Renal Denervation Market was valued at USD 1.03 billion in 2023. The market size is projected to grow at a CAGR of 31.60% to reach USD 9.34 billion by 2031.
Global Renal Denervation Market Overview
One minimally invasive catheter-based treatment for hypertension is renal denervation. Renal artery nerves are burned with radiofrequency ablation. Both blood pressure and nerve activity drop. When pharmacological therapy fails to provide relief, this process is typically employed to improve outcomes. Ultrasound or high-frequency pulses are used to eliminate the nerves in the wall of the renal artery. By lessening the sympathetic kidneys' activity, it reduces blood pressure.
Data Bridge Market research market report provides details of recent developments, trade regulations, market share, market trends on the basis of its segmentations and regional analysis, impact of market players, analysis of opportunities in terms of emerging revenue pockets, market regulations, strategic market growth analysis, market size, category wise market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research’s team of expert analysts. Our team will help you make informed market decisions to achieve business growth.
Global Renal Denervation Market Size
|
Global Renal Denervation Market Report Metric Details
|
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable 2016-2021)
|
|
Measuring Unit
|
USD Billion
|
|
Data Pointer
|
market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
An important and expanding global health concern is indicated by an increase in heart failure, hypertension, and chronic renal disease. These days, the majority of treatment plans for these illnesses centre on pharmaceutical and lifestyle changes, but blood pressure management rates and attempts to stop heart failure from getting worse. Data bridge Market Research took a dive into comprehensively analyzing the market and unveiled that the Global Renal Denervation Market is increasing at a CAGR of 31.60%. The size of the market is valued at USD 1.03 billion in 2023 and is expected to grow up to USD 9.34 billion by 2031.
Global Renal Denervation Market Dynamics
Global Renal Denervation Market Growth Drivers
Increasing Prevalence of Hypertension
The need for efficient treatment options like renal denervation is rising dramatically due to the increasing frequency of resistant hypertension, a condition in which patients' blood pressure cannot be managed even after taking several antihypertensive drugs. For patients who do not react to traditional medications, this surgery offers a viable option by targeting the sympathetic nerves in the renal arteries to lower blood pressure. Renal denervation technologies are gaining market share and attention as the number of people with this difficult condition rises and the need for cutting-edge, novel treatments to successfully manage their hypertension grows.Top of Form
Associated Beneficial Factors
The use of renal denervation therapy has been beneficial in lowering blood pressure. Consequently, it is anticipated that the advantages provided by these therapies—such as their longer half-lives, shorter treatment durations, and increased safety—will propel market expansion. Furthermore, technological developments in renal denervation devices may propel market expansion. In individuals with refractory hypertension symptoms, for example, the development of catheter-based procedures to remove renal nerves has demonstrated impressive benefits in controlling blood pressure. Catheter-based techniques also seem to be safer for the patient and make denervation of certain nerves easier.
Growing Awareness
Renal denervation is a cutting-edge therapeutic option that is gaining popularity as patients and medical professionals become more knowledgeable about its potential benefits and the significance of controlling hypertension. The need for renal denervation is increasing as more people and medical professionals realise that it can be an effective way to manage resistant hypertension, especially in situations where conventional treatments are ineffective. Renal denervation technology acceptance and investment are increasing due to increased awareness brought about by patient advocacy, medical education, and effective clinical outcomes. This is speeding up the market's growth.
Global Renal Denervation Market Growth Opportunities
Rising number of chronic diseases
Opportunities for market expansion are anticipated to arise throughout the forecast period as the patient pool for various chronic conditions, such as obesity in children and adults, is likely to develop.
The WHO estimates that in 2021, more than 39 million children under the age of five were overweight. The need for renal nerve denervation therapy is expected to increase as a result of this illness since obesity-related elevated amounts of leptin might cause the hypothalamus' blood vessels to expand, leading to hypertension.
Advancement in New Techniques
One of the primary things driving the renal denervation approach's adoption is sheer new abilities it introduces. One potential solution to the drawbacks of high-frequency-based renal denervation systems is the integration of ultrasonic technology into the system. Without making direct touch with the tissue, high-frequency sound waves containing ultrasonic energy can help eliminate nerves. This lessens the risk of renal artery injury. This feature is the reason why a large number of patients worldwide favour this procedure. Furthermore, incorporating technology into these kinds of healthful routines will greatly enhance their results.
Global Renal Denervation Market Size Growth Challenges
Healthcare System Variability
Variations in treatment methods, reimbursement regulations, and healthcare infrastructure can have a big impact on how widely renal denervation technologies are adopted and expand. Renal denervation technologies are anticipated to be rapidly accepted and incorporated into conventional treatment regimens in areas with developed healthcare systems, established reimbursement frameworks, and a strong medical infrastructure. On the other hand, renal denervation adoption may be slower and more uneven in regions with less established healthcare systems, restricted access to cutting-edge medical technologies, and variable or stringent reimbursement rules. These regional differences can impede the global adoption of renal denervation techniques and lead to unequal market growth.
Economic Downturns
Economic downturns or volatility may result in lower investment and healthcare budgets, which may have an immediate effect on the development of cutting-edge medical technology like renal denervation. Governments and healthcare organisations may experience financial difficulties during recessions, which could lead to reductions in elective procedures—including more expensive or sophisticated therapies like renal denervation. Furthermore, during financial downturns, less money may be allocated to healthcare innovation and technology development, which may postpone the development and uptake of these innovations, stifling market expansion and restricting patient access to potentially helpful medicines.
Global Renal Denervation Market Size Growth Restraints
Alternative Therapies
The availability and ongoing development of alternative hypertension treatments, such as medicine and lifestyle changes, may place restrictions on the use of renal denervation. Medications that effectively lower blood pressure as well as non-pharmacological approaches including diet, exercise, and weight control are tried-and-true, minimally intrusive ways to control hypertension. Renal denervation is a more intrusive treatment that needs specialised equipment and knowledge; if these alternatives become more effective and patient compliance increases, the perceived need for renal denervation may decrease. As a result, the market expansion and acceptance rates of renal denervation technologies may be limited by the availability of strong and developing treatment alternatives.
Painful Procedures
The emergence of pain during and shortly following renal denervation treatments is one of the major side effects. To reduce pain, the procedure is typically performed while sedated and with a local anaesthetic. In addition, the system is a little convoluted and complicated. A catheter is inserted into the femoral artery after a local anaesthetic injection into the area above the artery. Under X-ray control, a catheter, or fine tube, is pushed into the renal artery. The position inside the artery is verified by injecting a dye through the catheter. After that, a unique wire is inserted through the catheter to heat the arterial wall from the inside using high-frequency radiation. It is at this point when pain may start to manifest.
Global Renal Denervation Market Scope and Trends
|
Global Renal Denervation Market Segmentations Overview
|
||
|
Segments Type
|
Sub-Segments
|
|
|
Technology
|
Radiofrequency, Ultrasound, Micro-Infusion, Pharmacologic
|
|
|
Application
|
Hypertension, Heart Failure
|
|
|
Type
|
Catheters, RF Generator, Nerve Modifying Agents
|
|
|
End-User
|
Hospitals, Specialty Clinics, Research and Academic Institutes, Ambulatory Care Centers
|
|
Key Insight
- New multi-electrode radiofrequency catheters enable simultaneous ablation of multiple renal nerve sites, which can increase procedural efficiency and improve clinical outcomes.
- These days, sophisticated imaging technologies like real-time ultrasonography and fluoroscopy are integrated into modern radiofrequency systems to improve the accuracy of the ablation process and visualise kidney structures more clearly.
- The mechanisms causing renal denervation and its effect on hypertension are being better understood by research institutes. This involves researching the function of renal sympathetic nerves in the maintenance of blood pressure as well as the long-term consequences of their ablation.
- Renal denervation treatments may now be completed more quickly and effectively because to new protocols and techniques, which also shorten patients' stays in the ASC and lower total healthcare expenses.
Global Renal Denervation Market Regional Analysis – Market Trends
|
Global Renal Denervation Market Regional Overview
|
|
|
Regions
|
Countries
|
|
Europe
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe
|
|
APAC
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific
|
|
North America
|
U.S., Canada, and Mexico
|
|
MEA
|
Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East, and Africa
|
|
South America
|
Brazil, Argentina, and Rest of South America
|
Key Insights
- European regulatory bodies, such as the European Medicines Agency (EMA), have granted approvals for new renal denervation devices and technologies, facilitating their availability in European markets.
- In Europe, procedural accuracy and patient outcomes have improved with the development and use of sophisticated renal denervation technologies, such as enhanced ablation systems and multi-electrode catheters.
- Important clinical investigations on the safety and effectiveness of renal denervation have been carried out in North America, including the SPYRAL HTN trials and others. These studies support the technology's application in clinical practice and serve to validate it.
- Renal denervation operations are now more accessible in Saudi Arabia thanks to the development and growth of specialised centres for the treatment of hypertension and cardiovascular disease. The newest renal denervation technologies are currently available in major hospitals and healthcare institutes.
Global Renal Denervation Market Leading Players
- Medtronic (U.S.)
- Boston Scientific Corporation (U.S.)
- Abbott (U.S.)
- ReCor Medical, Inc. (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Terumo Corporation (Japan)
- Mercator MedSystems,Inc. (U.S.)
- Ablative Solutions, Inc. (U.S.)
- SympleSurgical Inc. (U.S.)
- Kona Medical Inc. (U.S.)
- Renal Dynamics Limited (U.K.)
- Otsuka Medical Devices Co., Ltd. (Tokyo)
Global Renal Denervation Market Recent Developments
- The precision and efficacy of treating hypertension are being improved through the use of sophisticated renal denervation devices, such as multi-electrode and ultrasound-based systems. The simultaneous ablation of several renal nerve locations is made possible by multi-electrode devices, which improves the procedure's uniformity and efficiency.
- High-frequency sound waves are used by ultrasound-based systems to precisely target nerve tissue, reducing injury to nearby structures and enhancing therapy results overall. These technical developments represent a major improvement in the treatment of high blood pressure and are especially helpful in treating resistant hypertension. They also provide more effective solutions where traditional methods may not be sufficient.
- Renal denervation operations are becoming increasingly popular in North America, mostly due to the rising body of solid clinical evidence supporting the procedure's safety and effectiveness in treating resistant hypertension.
- Recent developments in device technology, along with improved patient results, have strengthened confidence in these treatments.
- Modern devices with multi-electrode and complex energy delivery systems are now more readily available, which has made it easier to integrate them into clinical practice.
DBMR’s market report on Global Renal Denervation market takes you through valuable insights that can contribute to making several important business decisions. Based on our reports and research expertise you can create realistic growth strategies for your business.
SKU-